Protein arginine methylation in estrogen signaling and estrogen-related cancers

Trends in Endocrinology and Metabolism

Volumn 21, Issue 3, 2010, Pages 181-189

  Teyssier, Catherine ^a,b   Le Romancer, Muriel ^c,d   Sentis, Stéphanie ^c,d   Jalaguier, Stéphan ^e,f,g   Corbo, Laura ^c,d   Cavaillès, Vincent ^e,f,g  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CENTRE LÉON BÉRARD   (France)

^e INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^f UNIV MONTPELLIER   (France)

^g CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; LYSINE; N DEMETHYLASE; N(G) METHYLARGININE; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 1; PROTEIN ARGININE METHYLTRANSFERASE 4; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPLEX FORMATION; HORMONE ACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; ARGININE; BREAST NEOPLASMS; ESTROGENS; FEMALE; HUMANS; MALE; METHYLATION; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN-ARGININE N-METHYLTRANSFERASES; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 77949331053     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2009.11.002     Document Type: Review

References (78)

1. Bedford M.T., Clarke S.G. Protein arginine methylation in mammals: who, what, and why. Mol. Cell 2009, 33:1-13.
2. Bedford M.T., Richard S. Arginine methylation an emerging regulator of protein function. Mol. Cell 2005, 18:263-272.
3. Aletta J.M., Hu J.C. Protein arginine methylation in health and disease. Biotechnol. Annu. Rev. 2008, 14:203-224.
4. O'Malley B. The Year in Basic Science: nuclear receptors and coregulators. Mol. Endocrinol. 2008, 22:2751-2758.
5. Lonard D.M., O'Malley B.W. The expanding cosmos of nuclear receptor coactivators. Cell 2006, 125:411-414.
6. Rosenfeld M.G., et al. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 2006, 20:1405-1428.
7. Lee D.Y., et al. Role of protein methylation in regulation of transcription. Endocr. Rev. 2005, 26:147-170.
8. Augereau P., et al. The nuclear receptor transcriptional coregulator RIP140. Nucl. Recept. Signal. 2006, 4:e024.
9. Jones P.L., Shi Y.B. N-CoR-HDAC corepressor complexes: roles in transcriptional regulation by nuclear hormone receptors. Curr. Top. Microbiol. Immunol. 2003, 274:237-268.
10. Bjornstrom L., Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 2005, 19:833-842.
11. Migliaccio A., et al. Crosstalk between EGFR and extranuclear steroid receptors. Ann. N. Y. Acad. Sci. 2006, 1089:194-200.
12. Acconcia F., et al. Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol. Biol. Cell 2005, 16:231-237.
13. Greger J.G., et al. Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase. Mol. Cell. Biol. 2007, 27:1904-1913.
14. Azuma K., et al. Association of estrogen receptor alpha and histone deacetylase 6 causes rapid deacetylation of tubulin in breast cancer cells. Cancer Res. 2009, 69:2935-2940.
15. Litt M., et al. Histone arginine methylations: their roles in chromatin dynamics and transcriptional regulation. Biosci. Rep. 2009, 29:131-141.
16. Wysocka J., et al. Histone arginine methylation and its dynamic regulation. Front. Biosci. 2006, 11:344-355.
17. Pal S., Sif S. Interplay between chromatin remodelers and protein arginine methyltransferases. J. Cell. Physiol. 2007, 213:306-315.
18. Koh S.S., et al. Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J. Biol. Chem. 2001, 276:1089-1098.
19. Chen D., et al. Regulation of transcription by a protein methyltransferase. Science 1999, 284:2174-2177.
20. Le Romancer M., et al. Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol. Cell 2008, 31:212-221.
21. Lahusen T., et al. The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer. Breast Cancer Res. Treat. 2009, 116:225-237.
22. Harigopal M., et al. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome. Breast Cancer Res. Treat. 2009, 115:77-85.
23. Torres-Arzayus M.I., et al. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 2004, 6:263-274.
24. Kuang S.Q., et al. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice. Cancer Res. 2004, 64:1875-1885.
25. Feng Q., et al. Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly. Mol. Cell. Biol. 2006, 26:7846-7857.
26. Naeem H., et al. The activity and stability of the transcriptional coactivator p/CIP/SRC-3 are regulated by CARM1-dependent methylation. Mol. Cell. Biol. 2007, 27:120-134.
27. Lee Y.H., et al. Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:3611-3616.
28. Teyssier C., et al. Activation of nuclear receptor coactivator PGC-1alpha by arginine methylation. Genes Dev. 2005, 19:1466-1473.
29. Mostaqul Huq M.D., et al. Suppression of receptor interacting protein 140 repressive activity by protein arginine methylation. EMBO. J. 2006, 25:5094-5104.
30. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
31. Taverna S.D., et al. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat. Struct. Mol. Biol. 2007, 14:1025-1040.
32. O'Malley B.W., et al. Cracking the coregulator codes. Curr. Opin. Cell Biol. 2008, 20:310-315.
33. Mostaqul Huq M.D., et al. Post-translational modifications of nuclear co-repressor RIP140: a therapeutic target for metabolic diseases. Curr. Med. Chem. 2008, 15:386-392.
34. Huq M.D., et al. Lysine methylation of nuclear co-repressor receptor interacting protein 140. J. Proteome Res. 2009, 8:1156-1167.
35. Gupta P., et al. PKCepsilon stimulated arginine methylation of RIP140 for its nuclear-cytoplasmic export in adipocyte differentiation. PLoS ONE 2008, 3:e2658.
36. Berthet C., et al. Interaction of PRMT1 with BTG/TOB proteins in cell signalling: molecular analysis and functional aspects. Genes Cells 2002, 7:29-39.
37. Lin W.J., et al. The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J. Biol. Chem. 1996, 271:15034-15044.
38. Rouault J.P., et al. Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex. J. Biol. Chem. 1998, 273:22563-22569.
39. Robin-Lespinasse Y., et al. hCAF1, a new regulator of PRMT1-dependent arginine methylation. J. Cell Sci. 2007, 120:638-647.
40. Wang H., et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 2001, 293:853-857.
41. Huang S., et al. Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications. Genes Dev. 2005, 19:1885-1893.
42. Prevot D., et al. Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway. J. Biol. Chem. 2001, 276:9640-9648.
43. Xu W., et al. A methylation-mediator complex in hormone signaling. Genes Dev. 2004, 18:144-156.
44. Higashimoto K., et al. Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12318-12323.
45. Feng, Q. et al. (2009) Biochemical control of CARM1 enzymatic activity by phosphorylation. J. Biol. Chem. (in press).
46. Frietze S., et al. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Cancer Res. 2008, 68:301-306.
47. Pawlak M.R., et al. Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable. Mol. Cell. Biol. 2000, 20:4859-4869.
48. Yadav N., et al. Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:6464-6468.
49. Miller L.D., et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13550-13555.
50. van't Veer L.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
51. Richardson A.L., et al. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006, 9:121-132.
52. Finak G., et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 2008, 14:518-527.
53. Ivshina A.V., et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res. 2006, 66:10292-10301.
54. Hendrix N.D., et al. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res. 2006, 66:1354-1362.
55. Goulet I., et al. Alternative splicing yields protein arginine methyltransferase 1 isoforms with distinct activity, substrate specificity, and subcellular localization. J. Biol. Chem. 2007, 282:33009-33021.
56. Chang X., Han J. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. Mol. Carcinog. 2006, 45:183-196.
57. Chang X., et al. Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer 2009, 9:40.
58. Dong S., et al. Estrogen-enhanced peptidylarginine deiminase type IV gene (PADI4) expression in MCF-7 cells is mediated by estrogen receptor-alpha-promoted transfactors activator protein-1, nuclear factor-Y, and Sp1. Mol. Endocrinol. 2007, 21:1617-1629.
59. El Messaoudi S., et al. Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13351-13356.
60. Tokunaga E., et al. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. Eur. J. Cancer 2006, 42:629-635.
61. Spannhoff A., et al. Cancer treatment of the future: inhibitors of histone methyltransferases. Int. J. Biochem. Cell Biol. 2009, 41:4-11.
62. Lee Y.H., Stallcup M.R. Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation. Mol. Endocrinol. 2009, 23:425-433.
63. Krause C.D., et al. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. Pharmacol. Ther. 2007, 113:50-87.
64. Metivier R., et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
65. Cuthbert G.L., et al. Histone deimination antagonizes arginine methylation. Cell 2004, 118:545-553.
66. Wang Y., et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 2004, 306:279-283.
67. Hidaka Y., et al. Methylation of the guanidino group of arginine residues prevents citrullination by peptidylarginine deiminase IV. FEBS Lett. 2005, 579:4088-4092.
68. Raijmakers R., et al. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J. Mol. Biol. 2007, 367:1118-1129.
69. Chang B., et al. JMJD6 is a histone arginine demethylase. Science 2007, 318:444-447.
70. Webby C.J., et al. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science 2009, 325:90-93.
71. Kim J., et al. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep. 2006, 7:397-403.
72. Cote J., Richard S. Tudor domains bind symmetrical dimethylated arginines. J. Biol. Chem. 2005, 280:28476-28483.
73. Cheng D., et al. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Mol. Cell 2007, 25:71-83.
74. Bauer U.M., et al. Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep. 2002, 3:39-44.
75. Saal L.H., et al. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:7564-7569.
76. Cook J.R., et al. FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues. Biochem. Biophys. Res. Commun. 2006, 342:472-481.
77. Troffer-Charlier N., et al. Functional insights from structures of coactivator-associated arginine methyltransferase 1 domains. EMBO J. 2007, 26:4391-4401.
78. Teyssier C., et al. Requirement for multiple domains of the protein arginine methyltransferase CARM1 in its transcriptional coactivator function. J. Biol. Chem. 2002, 277:46066-46072.